Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovis (ENOV) Total Liabilities (2016 - 2026)

Enovis has reported Total Liabilities over the past 16 years, most recently at $2.3 billion for Q4 2025.

  • Quarterly Total Liabilities rose 8.74% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 8.74% year-over-year, with the annual reading at $2.3 billion for FY2025, 8.74% up from the prior year.
  • Total Liabilities was $2.3 billion for Q4 2025 at Enovis, down from $2.4 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $3.9 billion in Q4 2021 and troughed at $823.4 million in Q4 2022.
  • The 5-year median for Total Liabilities is $2.2 billion (2024), against an average of $2.1 billion.
  • Year-over-year, Total Liabilities tumbled 78.64% in 2022 and then surged 153.75% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $3.9 billion in 2021, then tumbled by 78.64% to $823.4 million in 2022, then soared by 32.2% to $1.1 billion in 2023, then skyrocketed by 97.9% to $2.2 billion in 2024, then grew by 8.74% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ENOV's Total Liabilities are $2.3 billion (Q4 2025), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025).